Effects and interactions in an environmentally relevant mixture of pharmaceuticals F Pomati, C Orlandi, M Clerici, F Luciani, E Zuccato Toxicological sciences 102 (1), 129-137, 2008 | 272 | 2008 |
Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4 M Molteni, D Marabella, C Orlandi, C Rossetti Cancer letters 235 (1), 75-83, 2006 | 134 | 2006 |
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization Immunity, 2020 | 78 | 2020 |
Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the ebolavirus glycoprotein P Gilchuk, N Kuzmina, PA Ilinykh, K Huang, BM Gunn, A Bryan, ... Immunity 49 (2), 363-374. e10, 2018 | 74 | 2018 |
Paring down HIV Env: design and crystal structure of a stabilized inner domain of HIV-1 gp120 displaying a major ADCC target of the A32 region WD Tolbert, N Gohain, M Veillette, JP Chapleau, C Orlandi, ML Visciano, ... Structure 24 (5), 697-709, 2016 | 56 | 2016 |
Cocrystal structures of antibody N60-i3 and antibody JR4 in complex with gp120 define more cluster A epitopes involved in effective antibody-dependent effector function against … N Gohain, WD Tolbert, P Acharya, L Yu, T Liu, P Zhao, C Orlandi, ... Journal of virology 89 (17), 8840-8854, 2015 | 56 | 2015 |
A single dose of modified vaccinia Ankara expressing Ebola virus like particles protects nonhuman primates from lethal Ebola virus challenge A Domi, F Feldmann, R Basu, N McCurley, K Shifflett, J Emanuel, ... Scientific Reports 8 (1), 864, 2018 | 53 | 2018 |
A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies C Orlandi, R Flinko, GK Lewis Journal of Immunological Methods 433, 51-58, 2016 | 46 | 2016 |
Targeting the late stage of HIV-1 entry for antibody-dependent cellular cytotoxicity: structural basis for Env epitopes in the C11 region WD Tolbert, N Gohain, N Alsahafi, V Van, C Orlandi, S Ding, L Martin, ... Structure 25 (11), 1719-1731. e4, 2017 | 39 | 2017 |
Molecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240 N Gohain, WD Tolbert, C Orlandi, J Richard, S Ding, X Chen, DA Bonsor, ... Scientific reports 6 (1), 36685, 2016 | 35 | 2016 |
Antigen-induced allosteric changes in a human IgG1 Fc increase low-affinity Fcγ receptor binding C Orlandi, D Deredge, K Ray, N Gohain, W Tolbert, AL DeVico, ... Structure 28 (5), 516-527. e5, 2020 | 30 | 2020 |
Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell‐mediated cytotoxicity assay J Pollara, C Orlandi, C Beck, RW Edwards, Y Hu, S Liu, S Wang, RA Koup, ... Cytometry Part A 93 (4), 436-447, 2018 | 24 | 2018 |
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication C Orlandi, G Forlani, G Tosi, RS Accolla Journal of Translational Medicine 9, 1-9, 2011 | 14 | 2011 |
A MUC16 IgG binding activity selects for a restricted subset of IgG enriched for certain simian immunodeficiency virus epitope specificities JR Schneider, X Shen, C Orlandi, T Nyanhete, S Sawant, AM Carias, ... Journal of virology 94 (5), 10.1128/jvi. 01246-19, 2020 | 6 | 2020 |
Concurrent Exposure of Neutralizing and Non-neutralizing Epitopes on a Single HIV-1 Envelope Structure K Ray, M Mengistu, C Orlandi, M Pazgier, GK Lewis, AL DeVico Frontiers in Immunology, 2019 | 6 | 2019 |
Induction of Fc-Mediated Effector Functions Against a Stabilized Inner Domain of HIV-1 gp120 Designed to Selectively Harbor the A32 Epitope Region ML Visciano, N Gohain, R Sherburn, C Orlandi, R Flinko, A Dashti, ... Frontiers in immunology 10, 2019 | 6 | 2019 |
Deciphering Fc-mediated Antiviral Antibody Functions in Animal Models AL Schmaljohn, C Orlandi, GK Lewis Frontiers in Immunology 10, 2019 | 4 | 2019 |
AIDS Vaccine 2013October 7–10, 2013Barcelona, Spain T Hertz AIDS Research and Human Retroviruses 29 (11), A-1, 2013 | 1 | 2013 |
Trogocytosis of viral immune complexes in the context of HIV-1 infection C Orlandi, R Flinko, K Ray, Y Hu, J Mamede, D Maric, T Hope, G Lewis JAIDS Journal of Acquired Immune Deficiency Syndromes 81, 78, 2019 | | 2019 |
P-D8 New insights on the human anti-HIV-1 Env antibody-mediated cell cytotoxicity (ADCC) against HIV-1 virus: Allosteric regulation of FcRs binding upon antigen engagement C Orlandi, D Deredge, K Ray, N Gohain, W Tolbert, M Pazgier, A DeVico, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 77, 60, 2018 | | 2018 |